Skip to main content

Table 12 Insurance status and cost of HD (excluding the cost of erythropoietin-stimulating agents, prescription medications, etc.), dialyzer reuse, HD hours per session, and HD sessions per week and numbers of HD and CAPD patients in the five countries

From: Present status of renal replacement therapy in Asian countries as of 2016: Cambodia, Laos, Mongolia, Bhutan, and Indonesia

Country

Insurance and cost of HD

Reuse or single-use

HD hours per session

HD sessions per week

No. of CAPD patients

No. of HD patients

Cambodia

100% by patient (45–60 USD)

Reuse (6 times)

4

1 to 3 (depends on patient)

Not available

300–500 (estimated)

Laos

100% by patient (50–70 USD)

Reuse (5 times)

4

1 to 3 (depends on patient)

3

Unknown

Bhutan

100% by government (30 USD)

Reuse (3 times)

4

2

Not available

150

Mongolia

100% by insurance (50 USD)

Single-use

4

3

9

485

Indonesia

90% by insurance (70 USD)

Reuse (see Fig. 3)

4.5

2

1243

11,689